{"corpus_id":84844238,"paper_sha":"edbfb4fcd2da67b33860772b2ba2519d1377bf27","doi":"10.1093/annonc/mdz108","arxiv_id":null,"pmid":30895304,"pmcid":"6594459","mag_id":2923501617,"dblp_id":null,"acl_id":null,"title":"Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers","year":2019,"publication_date":"2019-03-21","venue":"Annals of Oncology","journal":{"name":"Annals of Oncology","pages":"998 - 1004","volume":"30"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Medicine"],"reference_count":43,"citation_count":463,"influential_citation_count":21,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Algorithms","mj":false,"ui":"D000465"},{"d":"Antineoplastic Combined Chemotherapy Protocols","mj":false,"qs":[{"q":"therapeutic use","mj":false,"ui":"Q000627"}],"ui":"D000971"},{"d":"Artificial Intelligence","mj":true,"ui":"D001185"},{"d":"Carcinoma, Non-Small-Cell Lung","mj":false,"qs":[{"q":"diagnostic imaging","mj":true,"ui":"Q000000981"},{"q":"drug therapy","mj":true,"ui":"Q000188"},{"q":"immunology","mj":false,"ui":"Q000276"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D002289"},{"d":"Follow-Up Studies","mj":false,"ui":"D005500"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunotherapy","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D007167"},{"d":"Lung Neoplasms","mj":false,"qs":[{"q":"diagnostic imaging","mj":true,"ui":"Q000000981"},{"q":"drug therapy","mj":true,"ui":"Q000188"},{"q":"immunology","mj":false,"ui":"Q000276"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D008175"},{"d":"Machine Learning","mj":false,"ui":"D000069550"},{"d":"Melanoma","mj":false,"qs":[{"q":"diagnostic imaging","mj":false,"ui":"Q000000981"},{"q":"drug therapy","mj":true,"ui":"Q000188"},{"q":"immunology","mj":false,"ui":"Q000276"},{"q":"pathology","mj":true,"ui":"Q000473"}],"ui":"D008545"},{"d":"Predictive Value of Tests","mj":false,"ui":"D011237"},{"d":"Prognosis","mj":false,"ui":"D011379"},{"d":"Programmed Cell Death 1 Receptor","mj":false,"qs":[{"q":"antagonists & inhibitors","mj":false,"ui":"Q000037"},{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D061026"},{"d":"Survival Rate","mj":false,"ui":"D015996"},{"d":"Tomography, X-Ray Computed","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D014057"}],"chemicals":[{"n":"PDCD1 protein, human","ui":"C105992","reg":"0"},{"n":"Programmed Cell Death 1 Receptor","ui":"D061026","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"http://www.annalsofoncology.org/article/S0923753419312025/pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/edbfb4fcd2da67b33860772b2ba2519d1377bf27","s2_open_access_license":"CCBYNC","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Abstract Introduction Immunotherapy is regarded as one of the major breakthroughs in cancer treatment. Despite its success, only a subset of patients responds—urging the quest for predictive biomarkers. We hypothesize that artificial intelligence (AI) algorithms can automatically quantify radiographic characteristics that are related to and may therefore act as noninvasive radiomic biomarkers for immunotherapy response. Patients and methods In this study, we analyzed 1055 primary and metastatic lesions from 203 patients with advanced melanoma and non-small-cell lung cancer (NSCLC) undergoing anti-PD1 therapy. We carried out an AI-based characterization of each lesion on the pretreatment contrast-enhanced CT imaging data to develop and validate a noninvasive machine learning biomarker capable of distinguishing between immunotherapy responding and nonresponding. To define the biological basis of the radiographic biomarker, we carried out gene set enrichment analysis in an independent dataset of 262 NSCLC patients. Results The biomarker reached significant performance on NSCLC lesions (up to 0.83 AUC, P < 0.001) and borderline significant for melanoma lymph nodes (0.64 AUC, P = 0.05). Combining these lesion-wide predictions on a patient level, immunotherapy response could be predicted with an AUC of up to 0.76 for both cancer types (P < 0.001), resulting in a 1-year survival difference of 24% (P = 0.02). We found highly significant associations with pathways involved in mitosis, indicating a relationship between increased proliferative potential and preferential response to immunotherapy. Conclusions These results indicate that radiographic characteristics of lesions on standard-of-care imaging may function as noninvasive biomarkers for response to immunotherapy, and may show utility for improved patient stratification in both neoadjuvant and palliative settings.","claims":[{"public_id":"cl_73803dd6df5d3c5fd88f9269bb5624a2","status":"active","text":"Combining lesion-wide predictions on a patient level, immunotherapy response could be predicted with an AUC of up to 0.76 for both cancer types (P < 0.001), resulting in a 1-year survival difference of 24% (P = 0.02).","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_73803dd6df5d3c5fd88f9269bb5624a2"},{"public_id":"cl_4aaa175e6761973cfc6473cc437f04da","status":"active","text":"Gene set enrichment analysis in an independent dataset of 262 NSCLC patients found highly significant associations with pathways involved in mitosis, indicating a relationship between increased proliferative potential and preferential response to immunotherapy.","confidence":0.9,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_4aaa175e6761973cfc6473cc437f04da"},{"public_id":"cl_3d9b427be75aa6b1720f827ded24f9fb","status":"active","text":"Radiographic characteristics of lesions on standard-of-care imaging may function as noninvasive biomarkers for response to immunotherapy and may show utility for improved patient stratification in both neoadjuvant and palliative settings.","confidence":0.85,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_3d9b427be75aa6b1720f827ded24f9fb"},{"public_id":"cl_c3cd7ee9540570e0be1145422e1238aa","status":"active","text":"The AI-based radiomic biomarker reached significant performance on NSCLC lesions with up to 0.83 AUC (P < 0.001) and borderline significant for melanoma lymph nodes with 0.64 AUC (P = 0.05).","confidence":0.95,"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_c3cd7ee9540570e0be1145422e1238aa"}],"concepts":[{"public_id":"co_05a4033c0f6e1bbbfc0e801b2e7b6c01","status":"active","name":"NSCLC lesions","description":"Primary and metastatic lesions from non-small-cell lung cancer patients analyzed in the study.","types":["sample","lesion type"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_05a4033c0f6e1bbbfc0e801b2e7b6c01"},{"public_id":"co_05b37084c32d0aa28947d25f887b1022","status":"active","name":"patient-level prediction","description":"Combining lesion-wide predictions to predict immunotherapy response at the patient level.","types":["method","prediction approach"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_05b37084c32d0aa28947d25f887b1022"},{"public_id":"co_56b5d24a127f39defa6b19c5548bf228","status":"active","name":"gene set enrichment analysis","description":"Analysis performed on an independent dataset of 262 NSCLC patients to define the biological basis of the radiographic biomarker.","types":["method","analysis"],"aliases":["GSEA"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_56b5d24a127f39defa6b19c5548bf228"},{"public_id":"co_63b7bbe1c24c07e984892eeacfb582b9","status":"active","name":"AI-based radiomic biomarker","description":"A machine learning biomarker developed from AI-based characterization of pretreatment contrast-enhanced CT imaging data to distinguish immunotherapy responding from nonresponding lesions.","types":["method","biomarker"],"aliases":["machine learning biomarker"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_63b7bbe1c24c07e984892eeacfb582b9"},{"public_id":"co_69f734e0b96afac49db02166811bfabd","status":"active","name":"radiographic characteristics","description":"Quantitative features of lesions extracted from standard-of-care contrast-enhanced CT imaging data.","types":["feature","imaging characteristic"],"aliases":["radiomic features"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_69f734e0b96afac49db02166811bfabd"},{"public_id":"co_7423b5713c5dfba1b19bfc4c81e2fc1c","status":"active","name":"patient stratification","description":"Improved grouping of patients for treatment decisions in neoadjuvant and palliative settings based on the biomarker.","types":["application","clinical use"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_7423b5713c5dfba1b19bfc4c81e2fc1c"},{"public_id":"co_76191c4b6871e8074c9adde9bf581e30","status":"active","name":"melanoma lymph nodes","description":"Lymph node lesions from melanoma patients analyzed in the study.","types":["sample","lesion type"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_76191c4b6871e8074c9adde9bf581e30"},{"public_id":"co_834930c3139e0fe1d80e1580b1e8655c","status":"active","name":"mitosis pathways","description":"Pathways involved in mitosis that showed highly significant associations with the radiographic biomarker, indicating increased proliferative potential.","types":["biological pathway"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_834930c3139e0fe1d80e1580b1e8655c"},{"public_id":"co_84271d8fc98733c13a9fb787041921ac","status":"active","name":"proliferative potential","description":"The capacity for cell proliferation, linked to preferential response to immunotherapy in the study.","types":["biological property"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_84271d8fc98733c13a9fb787041921ac"},{"public_id":"co_955040ae408255277546c9e5d17a810d","status":"active","name":"immunotherapy response","description":"The outcome of whether a patient responds to anti-PD1 therapy, used as the prediction target.","types":["outcome","phenotype"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_955040ae408255277546c9e5d17a810d"},{"public_id":"co_b1ccbff383056352ee16e74f0252bd87","status":"active","name":"noninvasive biomarkers","description":"Biomarkers derived from imaging that do not require invasive procedures, proposed for immunotherapy response prediction.","types":["biomarker","method"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_b1ccbff383056352ee16e74f0252bd87"},{"public_id":"co_e2eec5950c4d38658a7df003f32be5da","status":"active","name":"1-year survival difference","description":"A 24% difference in 1-year survival observed between predicted responder and nonresponder groups.","types":["measurement","outcome"],"aliases":[],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e2eec5950c4d38658a7df003f32be5da"}],"external_ids":{"DOI":"10.1093/annonc/mdz108","ArXiv":null,"PubMed":30895304,"PubMedCentral":"6594459","MAG":2923501617,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"http://www.annalsofoncology.org/article/S0923753419312025/pdf","landing_url":"https://www.semanticscholar.org/paper/edbfb4fcd2da67b33860772b2ba2519d1377bf27","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNC","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":634208,"paper_uid":"dacaf231-6287-4777-962c-30266c623281","canonical_identity":{"paper_id":634208,"paper_uid":"dacaf231-6287-4777-962c-30266c623281","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/84844238"}